Drug Discovery Solutions
-
ADCs: From Design To Development
1/4/2024
Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.
-
SUREtechnology Platform™
8/4/2023
Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.
-
NanoAssemblr® Spark™: Freedom To Discover
4/14/2022
The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.
-
Early Phase Bioassays And Analytics
6/26/2024
The development of phase-appropriate, tailored bioassays is crucial. By identifying promising candidates, bioassays streamline the development process, enabling informed decision-making.
-
Research And Development Services For Gene Therapies
9/16/2025
Our mission is clear: to help sponsors reduce costs, shorten timelines, and de-risk development, so they can achieve critical milestones, secure investments, and advance life-changing therapies.
-
CHEF1™ Expression Technology
2/17/2022
The platform accelerates development of cell lines for cGMP production by using robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and proprietary expression plasmids, to rapidly produce high levels of recombinant protein.
-
Protein Degraders: From Discovery To Development
11/18/2025
Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.
-
Pharma Services Fill, Finish & Drug Delivery CDMO
11/7/2025
Sterile fill-finish and device assembly capabilities span global sites, offering scalable solutions, analytical testing, and regulatory compliance for combination products and small-batch technical programs.
-
CRISPR/Cas9 And Cas9 Variants
9/30/2025
A quick overview of this industry-changing technology as well as the newer Cas9 variants that expand its use.
-
TARGATT™ CHO Cells: Rapid, Stable CHO Cell Generation For Bioproduction
9/30/2025
With our proprietary TARGATT™ technology for site-specific integration of large DNA fragments, we’ve developed a series of TARGATT™ “master” cell lines, including engineered CHO.